• Seeking Alpha

Chemomab Announces Multiple Presentations at AASLD The Liver Meeting® 2025 Featuring Clinical Data from the Nebokitug Phase 2 Trial in Primary Sclerosing Cholangitis

Seeking Alpha / 16 hours ago 2 Views

Chemomab announced three presentations "of distinction" at AASLD The Liver Meeting® 2025 featuring clinical data from the nebokitug Phase 2 trial in PSC.
Read more
  • Source:
  • GlobeNewswire - News about Public Companies
Previous post
STRATA Skin Sciences Announces CMS Recognition of Expanded CPT Codes for Inflammatory and Autoimmune Dermatologic Conditions with Company Anticipating Wider Excimer Adoption Ahead Of 2027 CPT Expansion
Next post
Enphase Energy IQ8 Microinverters Power Solar Projects at Gas Stations Worldwide

Comments

Just Posted

  • Admirals Group AS Announces Cancellation of Financial Services Permission for Admirals MENA Limited (UAE)

    4 hours from now

  • Admirals Group AS teatab Admirals MENA Limitedi (Araabia Ühendemiraadid) finantsteenuste loa tühistamisest

    4 hours from now

  • OMS Energy啟動AI+機器人計劃 進軍商機龐大的管道油檢測及維修市場

    4 hours from now

  • Nokia and LMT sign strategic agreement to develop tactical defense solution for the Baltics

    4 hours from now

  • OMS Energy initiates AI+ Robotics research and development to enter the lucrative pipeline oil inspection and maintenance market

    4 hours from now

Tags

  • SA Transcripts
  • TOU:CA
  • Gold Mining Bull
  • TPZ
  • NG1:COM
  • CHK
  • TRMLF
  • fivn
  • CGIFF
  • CHE.UN:CA

Reviews

Categories

  • Seeking Alpha 1897

Categories

  • Seeking Alpha 1897

Pages

Tags

  • SA Transcripts
  • TOU:CA
  • Gold Mining Bull
  • TPZ
  • NG1:COM
  • CHK
  • TRMLF
  • fivn
  • CGIFF
  • CHE.UN:CA

Copyright News That Move � 2018. All Rights Reserved

  • Seeking Alpha
  • Trade Halts